<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>William Duncan</string-name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Travis Allen</string-name>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Jonathan Bona</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Olivia Helfer</string-name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Barry Smith</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Alan Ruttenberg</string-name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Alexander D. Diehl</string-name>
          <email>addiehl@buffalo.edu</email>
          <xref ref-type="aff" rid="aff0">0</xref>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Department of Biomedical Informatics</institution>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>Department of Neurology University at Buffalo Buffalo</institution>
          ,
          <addr-line>NY</addr-line>
          ,
          <country country="US">USA</country>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution>Department of Philosophy</institution>
        </aff>
        <aff id="aff3">
          <label>3</label>
          <institution>NYS Center of Excellence in Bioinformatics and Life Sciences</institution>
        </aff>
        <aff id="aff4">
          <label>4</label>
          <institution>Oral Diagnostics Sciences</institution>
        </aff>
      </contrib-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>-</title>
      <p>A major problem with monoclonal antibody-associated data
is that data producers typically report antibody clones or target
markers using non-standardized terminology:</p>
    </sec>
    <sec id="sec-2">
      <title>CD3 vs. CD3e (protein names)</title>
    </sec>
    <sec id="sec-3">
      <title>HIT3e vs. UCHT1 (antibody clones for CD3e)</title>
      <p>550367 vs. 300401 (catalog numbers for anti-CD3e
antibody reagents)</p>
      <p>In order to address this problem, we have created the
ImmPort Antibody Ontology (AntiO) to provide a source of
standardized names for monoclonal antibodies and their protein
targets for use by ImmPort investigators and the scientific
community in general, and to provide robust querying for
monoclonal antibody reagents via a variety of criteria.</p>
    </sec>
    <sec id="sec-4">
      <title>II. METHODS</title>
      <p>
        We curated monoclonal antibody-protein target
relationships by identifying names and information about
monoclonal antibodies based on published papers, data
submissions to ImmPort, and commercial monoclonal products
for immunology research such as the BD Lyoplate products.
We selected standardized monoclonal antibody names (clone
names) and curated information about the protein targets of the
antibodies using Protein Ontology and UniProt identifiers [
        <xref ref-type="bibr" rid="ref14 ref2">2</xref>
        ].
For both the monoclonal antibody clone names, and the protein
targets of the monoclonal antibodies, we have included many
additional synonyms to facilitate querying.
      </p>
      <p>
        The resulting antibody registry was transformed into the
AnitO ontology using the Reagent Ontology (ReO) as a
paradigm for the representation of monoclonal antibody
reagents [
        <xref ref-type="bibr" rid="ref16 ref3">3</xref>
        ]. Monoclonal antibodies are classified via isotype
and species of origin and are formally related to their protein
targets via the recognizes relation. For example, monoclonal
antibody clone HI100 recognizes some ‘receptor-type
tyrosineprotein phosphatase C isoform CD45RA’. We supplemented
the information in AntiO by creating classes for entries in the
NIF Antibody Registry [
        <xref ref-type="bibr" rid="ref4">4</xref>
        ] that represent products that contain
particular monoclonal antibody clones. These classes are types
of ‘monoclonal antibody offering’ in our ontology and are
linked to clone name classes via has_part relations. We have
also mined and standardized additional information from the
NIF Antibody Registry that is associated with particular
monoclonal antibody offering classes, including information
about product vendors, catalog numbers, conjugations
(fluorchromes, biotin, etc.) of antibody products, antibody
species specificity, and experimental usage.
      </p>
      <p>
        AntiO is built in an automated fashion using scripts that
combine information about monoclonal antibodies and their
targets found in curated spreadsheets with information
textmined from relevant NIF Antibody Registry entries to create a
base set of OWL2 modular ontologies that are imported into
the AntiO ontology (see Figure 1) along with import files for
ReO and Protein Ontology terms. Additional terms from the
Ontology for Biomedical Investigations [
        <xref ref-type="bibr" rid="ref5">5</xref>
        ], the BioAssay
Ontology [
        <xref ref-type="bibr" rid="ref6">6</xref>
        ], the Molecular Interactions Ontology [
        <xref ref-type="bibr" rid="ref7">7</xref>
        ], and the
NCBI Taxonomy [
        <xref ref-type="bibr" rid="ref8">8</xref>
        ] are included as MIREOT’ed terms as
well [
        <xref ref-type="bibr" rid="ref9">9</xref>
        ]. The resulting combined ontology is viewable and
queryable in Protégé 5 [
        <xref ref-type="bibr" rid="ref10">10</xref>
        ], and is loaded into a publicly
available RDF triple store for SPARQL queries.
      </p>
    </sec>
    <sec id="sec-5">
      <title>III. RESULTS</title>
      <p>AntiO contains 941 monoclonal antibodies of common use
in immunology experiments, and represents about 30,000
monoclonal antibody products from 80 vendors based on
information derived from the NIF Antibody Registry. We have
included the NIF ‘AB_XXXXXX’ identifiers as part of our
monoclonal antibody offering labels</p>
      <p>
        The AntiO triple store is based on OWLIM [
        <xref ref-type="bibr" rid="ref11">11</xref>
        ], is
prereasoned, and contains over a million RDF triples. A variety of
queries using AntiO are possible. One can for instance search
for all monoclonal antibodies that have a particular protein
target (Figure 2). Or, similarly, all monoclonal antibody
offerings (products) from a given vendor that have a particular
target. More indirect querying is possible; for instance, one can
search for the protein targets of monoclonal antibodies using
only the catalog number of the products used. There are
additional ways to search as well; one can limit searches to
antibodies that work only in particular types of experiments,
for instance. We have created a Bitbucket repository and wiki
to provide information about the ontology, as well as example
SPARQL queries (see Table 1 for URLs).
      </p>
      <p>Important URLs
http://protein.ctde.net:8080/openrdfworkbench/repositories/antio/query
https://bitbucket.org/wdduncan/antio/wiki/Home</p>
    </sec>
    <sec id="sec-6">
      <title>IV. DISCUSSION</title>
      <p>Through careful curation and data extraction using
computer programs, we have developed an ontology of
monoclonal antibodies used in immunological research with a
focus on ImmPort clinical studies and other recently published
papers in immunology. Our effort developing AntiO is
complementary to existing antibody registries. While such
resources let researchers find useful antibodies and the
companies that produce them, they do not provide standardized
terms for clone names, targets of the antibodies, conjugations,
etc. and so are difficult to use computationally. In collaboration
with the NIH-funded NIF Antibody Registry, we have
developed a framework that will allow researchers to more
easily query for monoclonal antibodies, the vendors that sell
them, and their protein targets and experimental usage, and
provides standardized terminology for all these data types and
more. Our long-term goal is to develop web interfaces that will
enable submitters of data not only to query for monoclonal
antibodies and their targets, but also facilitate the finding of
experimental results, such as clinical studies within the
ImmPort system, in which particular monoclonal antibodies
were used.</p>
      <p>
        Of further note is our reuse within AntiO of the compiled
NIF Antibody Registry data on antibody products, which is
part of the Research Resource Identification Project [
        <xref ref-type="bibr" rid="ref4">4</xref>
        ]. By
associating the monoclonal antibody offerings in AntiO with
the RRIDs provided by NIF Antibody Registry, we ensure
AntiO contributes to the goals of the Research Resource
Identification Project by linking to this common resource to
enable better reuse and integration of scientific data while
adding value to the NIF Antibody Registry data through our
careful curation and standardization steps.
      </p>
    </sec>
    <sec id="sec-7">
      <title>ACKNOWLEDGMENT We thank Sanchita Bhattacharya, Patrick Dunn, Atul Butte, Matthew Brush, Melissa Haendel, and Anita Bandrowski for helpful comments and support.</title>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          [1]
          <string-name>
            <surname>Bhattacharya</surname>
            <given-names>S</given-names>
          </string-name>
          , et al.,
          <article-title>“ImmPort: disseminating data to the public for the future of immunology,”</article-title>
          <source>Immunol Res</source>
          .
          <year>2014</year>
          ,
          <volume>58</volume>
          :
          <fpage>234</fpage>
          -
          <lpage>9</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          [2]
          <string-name>
            <surname>Natale</surname>
            <given-names>DA</given-names>
          </string-name>
          , et al.,
          <article-title>“Protein Ontology: a controlled structured network of protein entities</article-title>
          ,
          <source>” Nucleic Acids Res</source>
          .
          <year>2014</year>
          ,
          <volume>42</volume>
          :
          <fpage>D415</fpage>
          -
          <lpage>21</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          [3]
          <string-name>
            <surname>Brush</surname>
            <given-names>MH</given-names>
          </string-name>
          , et al., “
          <article-title>Developing a Reagent Application Ontology within the OBO Foundry</article-title>
          ,”
          <year>2011</year>
          , http://ceur-ws.
          <source>org/</source>
          Vol-
          <volume>833</volume>
          /paper32.pdf.
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          [4]
          <string-name>
            <surname>Bandrowski</surname>
            <given-names>A</given-names>
          </string-name>
          , et al., “
          <article-title>The Resource Identification Initiative: A cultural shift in publishing</article-title>
          ,”
          <fpage>F1000Res</fpage>
          .
          <year>2015</year>
          ,
          <volume>4</volume>
          :
          <fpage>134</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          [5]
          <string-name>
            <surname>Bandrowski</surname>
            <given-names>A</given-names>
          </string-name>
          , et al.,
          <source>“The Ontology for Biomedical Investigations,” PLoS One</source>
          .
          <year>2016</year>
          ,
          <volume>11</volume>
          :
          <fpage>e0154556</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          [6]
          <string-name>
            <surname>Visser</surname>
            <given-names>U</given-names>
          </string-name>
          , et al.,
          <article-title>“BioAssay Ontology (BAO): a semantic description of bioassays and high-throughput screening results</article-title>
          ,
          <source>” BMC Bioinformatics</source>
          .
          <year>2011</year>
          ,
          <volume>12</volume>
          :
          <fpage>257</fpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          [7]
          <string-name>
            <surname>Orchard</surname>
            <given-names>S</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Kerrien</surname>
            <given-names>S</given-names>
          </string-name>
          , “
          <article-title>Molecular interactions and data standardisation</article-title>
          ,”
          <source>Methods Mol Biol</source>
          .
          <year>2010</year>
          ,
          <volume>604</volume>
          :
          <fpage>309</fpage>
          -
          <lpage>18</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          [8]
          <string-name>
            <surname>Sayers</surname>
            <given-names>EW</given-names>
          </string-name>
          , et al., “
          <article-title>Database resources of the National Center for Biotechnology Information</article-title>
          ,”
          <source>Nucleic Acids Res</source>
          .
          <year>2009</year>
          ,
          <volume>37</volume>
          :
          <fpage>D5</fpage>
          -
          <lpage>15</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          [9]
          <string-name>
            <surname>Courtot</surname>
            <given-names>M</given-names>
          </string-name>
          , et al. “
          <article-title>MIREOT: The minimum information to reference an external ontology term</article-title>
          ,” Applied Ontology.
          <year>2011</year>
          ,
          <volume>6</volume>
          :
          <fpage>23</fpage>
          -
          <lpage>33</lpage>
          .
        </mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation>[10] http://protege.stanford.edu</mixed-citation>
      </ref>
      <ref id="ref11">
        <mixed-citation>
          [11]
          <string-name>
            <surname>Kiryakov</surname>
            <given-names>A</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Ognyanov</surname>
            <given-names>D</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Manov</surname>
            <given-names>D</given-names>
          </string-name>
          , “
          <article-title>OWLIM-a pragmatic semantic repository for OWL</article-title>
          .”
          <year>2005</year>
          , In Web Information Systems EngineeringWISE 2005 Workshops, Springer Berlin Heidelberg.
        </mixed-citation>
      </ref>
      <ref id="ref12">
        <mixed-citation>
          <article-title>?r1 owl:onProperty has_part: . ?r1 owl:someValuesFrom ?clonet</article-title>
          .
        </mixed-citation>
      </ref>
      <ref id="ref13">
        <mixed-citation>
          <article-title>?offeringt rdfs:subClassOf ?r1</article-title>
          .
        </mixed-citation>
      </ref>
      <ref id="ref14">
        <mixed-citation>
          <article-title>?r2 owl:onProperty is_sold_by: . ?r2 owl:hasValue ?vendori</article-title>
          .
        </mixed-citation>
      </ref>
      <ref id="ref15">
        <mixed-citation>
          <article-title>?offeringt rdfs:subClassOf ?r2</article-title>
          .
        </mixed-citation>
      </ref>
      <ref id="ref16">
        <mixed-citation>
          <article-title>?r3 owl:onProperty recognizes: . ?r3 owl:someValuesFrom ?targett</article-title>
          .
        </mixed-citation>
      </ref>
      <ref id="ref17">
        <mixed-citation>
          <article-title>?clonet rdfs:subClassOf ?r3</article-title>
          .
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>